Can specific vessel‐based papulopustular lesions of Behçet's disease be differentiated from nonspecific follicular‐based lesions clinically?

Boyvat, Ayşe; Heper, Aylın Okçu; Koçyiğit, Pelin; Erekul, Selim; Gürgey, Erbak

doi:10.1111/j.1365-4632.2006.02797.x

Cited by 18 publications

(17 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…29 According to the ISG diagnostic criteria, acneiform lesions in postadolescent patients who are not on systemic corticosteroid treatment are interpreted as a sign of Behçet's syndrome. 16 In studies evaluating the papulopustular lesions of Behçet's patients, the mean age of the patients is greater than 30 years.. [29][30][31] Acne vulgaris also can be observed in 20% of men and 35% of women over the age of 30, according to one study. 32 Postadolescent acne persisting beyond the age of 25 years usually is seen in women during the last week of the menstrual cycle.…”

Section: Papulopustular Lesionsmentioning

confidence: 94%

See 1 more Smart Citation

Behçet’s syndrome: Facts and controversies

Mat¹,

Yurdakul²,

Sevim³

et al. 2013

Clinics in Dermatology

View full text Add to dashboard Cite

Section: Papulopustular Lesionsmentioning

confidence: 94%

“…Of these papulopustular lesions, 13% (3 of 23) showed findings consistent with leukocytoclastic vasculitis. 30 …”

Section: Papulopustular Lesionsmentioning

confidence: 97%

Behçet’s syndrome: Facts and controversies

Mat¹,

Yurdakul²,

Sevim³

et al. 2013

Clinics in Dermatology

View full text Add to dashboard Cite

“…PPL klinikte en sık gözlenen deri belirtisidir 40 . Hastaların %40-70'inde beklenen bir bulgudur 41 . Çalışmamızda literatüre dayanılarak hastaların seboreik olmayan bölgelerindeki, foliküler yerleşim göstermeyen eritemli papül ve püstüller PPL olarak kabul edilmiştir 42 .…”

Section: Discussionunclassified

“…PPL çoğunlukla alt ekstremiteye yerleşir, ancak daha az sıklıkla gövde ile vücudun daha görünür bölgeleri olan üst ekstremite, yüz ve boyunda da görülebilirler 41 . Görünümü etkileyen deri lezyonlarının ciddi bir klinik semptoma yol açmaksızın psikososyal hayat üzerinde olumsuz etkileri olabilir.…”

Section: Discussionunclassified

Quality of life in patients with Behcet's disease and Recurrent aphthous stomatitis

Ayanoğlu¹,

Gürler²,

Gündüz³

et al. 2015

TURKDERM

View full text Add to dashboard Cite

Background and Design:Behçet's disease (BD) is an important cause of morbidity and mortality. Recurrent aphthous stomatitis (RAS) is a condition affecting oral health-related quality of life (QoL). In this study, we aimed to evaluate QoL of BD patients by using the Behçet's disease quality of life instrument (BDQLI) and to compare the QoL of patients with BD with that of patients with RAS and healthy controls. Materials and Methods: Forty patients with BD and 40 patients with RAS and 40 healthy subjects with similar sociodemographic characteristics were included in the study. We used the BDQLI to evaluate QoL of patients with BD and the Dermatology-specific quality of life instrument for comparison of QqL between patients with BD and RAS. 36-Item Short Form Health Survey and clinical data form were applied in all participants. The results were analyzed statistically. The power of the study was 99%. Results: QoL of patients with BD were lower than that of healthy controls. It was observed that patients with BD had decreased physical functions, impaired perception of pain and poor general health (p<0.001, p=0.001, p=0.016, <0.001). Physical functions were decreased and perception of general heath was worse in patients with RAS compared to healthy controls (p=0.018, p=0.021). There was no difference in

show abstract

“…Similarly, the histologic fi nding in papulopustular lesions may overlap with those of bacterial folliculitis, but the fi nding of lymphocytic vasculitis should only be present in BD lesions [ 16 ]. In any case, the clinical separation of vessel-based papulopustular lesions of BD cannot be reliably distinguished from nonspecifi c folliculitis [ 17 ].…”

Section: Diagnosing Behçet's Diseasementioning

confidence: 99%

Behçet’s disease: Recent advances in early diagnosis and effective treatment

Calamia

Kaklamanis²

2008

Curr Rheumatol Rep

View full text Add to dashboard Cite

Behçet's disease (BD) is a chronic, multisystem, inflammatory disorder that is classified among the systemic vasculitidies. Its cause has yet to be determined, but genetic and environmental factors and immune dysregulation are thought to play a role in its pathogenesis. The diagnosis of the disease and recognition and separation from disorders that may mimic BD may be difficult, especially in areas where the disease is uncommon. Certainty as to the best treatments for the various manifestations of BD is often unclear due to limited randomized controlled trials. However, existing consensus statements and expert opinions should help to guide therapy. This review examines important recent contributions to help the clinician more readily recognize patients with the disease and institute appropriate care.

show abstract

Can specific vessel‐based papulopustular lesions of Behçet's disease be differentiated from nonspecific follicular‐based lesions clinically?

Abstract: Clinical examination may not be sufficient to predict the dermatopathologic pattern in all lesions. Papulopustular lesions with no specific clinical and histopathologic features may create problems in the diagnosis of Behçet's disease.

Cited by 18 publications

References 8 publications

Behçet’s syndrome: Facts and controversies

Behçet’s syndrome: Facts and controversies

Quality of life in patients with Behcet's disease and Recurrent aphthous stomatitis

Behçet’s disease: Recent advances in early diagnosis and effective treatment

Contact Info

Product

Resources

About